Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Summary
Transcatheter Repair for Patients with Tricuspid Regurgitation.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2023 – Oct 2025Where it's discussed
-
X / Twitter189 posts
-
News132 articles
-
Facebook8 posts
-
YouTube4 videos
-
Blogs3 articles
AI synopsis
What people are saying
Discussions emphasize the safety and promising results of transcatheter tricuspid valve repair, with phrases like 'impactful results' and comments on new systems, illustrating high interest and engagement. Meanwhile, some posts critique the trial's limited impact on mortality and hospitalization, reflecting a nuanced view on its overall influence.
Most discussions recognize the safety and potential benefits of the transcatheter repair technique, reflecting general support with some critique about its limitations informing moderate agreement.
The discussions show high interest, with frequent mentions of the research, new systems, and clinical implications, indicating active engagement.
Posts include technical details, references to trials like TRILUMINATE, and expressions of appreciation for research advancements, demonstrating thoughtful engagement.
Users acknowledge the significance of the study in advancing minimally invasive treatments, though some note limitations, suggesting moderate impact on clinical practice.
Abstract in brief
- The study investigated the effectiveness of transcatheter edge-to-edge repair (TEER) for treating severe tricuspid regurgitation, comparing it to standard medical therapy in a randomized trial involving 350 patients across North America and Europe.
- Results showed that TEER significantly improved quality of life scores and reduced the severity of tricuspid regurgitation at 30 days, with a favorable primary end point outcome, although it did not significantly reduce death, surgery, or hospitalization rates within one year.
- Overall, TEER was considered safe, with most patients experiencing manageable procedure-related risks and improved symptoms, suggesting it as a promising option for managing this debilitating condition.
Top posts
Most liked on X and Bluesky重度の三尖弁閉鎖不全症に対するカテーテル治療 vs. 薬物治療の無作為化比較試験。残念ながら死亡や心不全入院では差がでず、生活の質はカテーテル治療で改善した。 Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/YLz7nwejZW https://t.co/ZMcLJi22Ce
#EAPCI Members
This week’s most cited articles: 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/ZWObb9Xl6T #cardiology https://t.co/JrGr819UMr
For patients with severe tricuspid regurgitation, transcatheter edge-to-edge repair (TEER) has emerged as a safe and potentially effective treatment option. Read the full TRILUMINATE Pivotal trial Research Summary: https://t.co/ZWObb9WNhl
All mentions
Advances in Tricuspid Valve Interventions and Lipid-Lowering Therapies
An update in trial interpretation CI and Pvalues percutaneous tricuspid interventions and news on HDL and humility in Medicine are the topics John Mandrola MD covers in this weeks podcast. This podcast is intended for…
Advances in Cardiology Treatments and Genetic Insights April 2024
This week's cardiology update covers statins and diabetes, antiarrhythmic drugs in serious heart disease, and latest research on PVC suppression in patients with NICM and ICDs.
Transcatheter Repair for Severe Tricuspid Regurgitation Effectiveness and Safety
This video discusses the effectiveness of transcatheter edge-to-edge repair for severe tricuspid regurgitation, highlighting improvements in quality of life and symptom relief, while noting the procedure's safety…
Advances in Tricuspid Regurgitation Treatment Using Transcatheter Repair
This week's podcast discusses low-value processes like tricuspid valve interventions with pacing leads, featuring insights from Dr. John Mandrola MD. It also covers the effectiveness and safety of transcatheter…
RT @PPibarot: Triluminate Trial just published in NEJM: Tricuspid TEER was safe for patients with severe tricuspid regurgitation, reduced t…
8/ Severe TR pts w/ high surgical risk. New TriClip system in TRILUMINATE trial https://t.co/ORlP57cX8K & transcatheter tricuspid valve replacement system (TRISCEND II trial) - @UCSFCardiology is one of the first in the country to use these techniques.
RT @ScrippsCVFellow: Comprehensive lecture this AM by the TV master himself @matthewjpricemd about TV interventions currently in clinical t…
RT @ovidiogarciav: @matthewjpricemd @michaelTCTMD Dear Matthew, In the abstract of Triluminate QoL improvement was only given by KCCQ. Here…
RT @ovidiogarciav: @matthewjpricemd @michaelTCTMD Dear Matthew, In the abstract of Triluminate QoL improvement was only given by KCCQ. Here…
@matthewjpricemd @michaelTCTMD Dear Matthew, In the abstract of Triluminate QoL improvement was only given by KCCQ. Here the abstract https://t.co/DicRZYIlix
RT @ScrippsCVFellow: Comprehensive lecture this AM by the TV master himself @matthewjpricemd about TV interventions currently in clinical t…
RT @ScrippsCVFellow: Comprehensive lecture this AM by the TV master himself @matthewjpricemd about TV interventions currently in clinical t…
RT @ScrippsCVFellow: Comprehensive lecture this AM by the TV master himself @matthewjpricemd about TV interventions currently in clinical t…
Comprehensive lecture this AM by the TV master himself @matthewjpricemd about TV interventions currently in clinical trials, review of the latest data for TTVR/clip. We are grateful to train at an institution so involved in the research on the TV frontier! https://t.co/mYeKQg4V1e https://t.co/d0gvZ2DBYa
Full article: https://t.co/ocJ5zM975f
RT @NEJM: This week’s most cited articles: 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/ZWObb9Xl6T #ca…
RT @ZHeart11768530: Don't miss !!!! This week’s most cited #cardiology articles @NEJM 1. Transcatheter Repair for Patients with Tricuspid…
RT @NEJM: This week’s most cited articles: 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/ZWObb9Xl6T #ca…
RT @NEJM: This week’s most cited articles: 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/ZWObb9Xl6T #ca…
RT @ZHeart11768530: Don't miss !!!! This week’s most cited #cardiology articles @NEJM 1. Transcatheter Repair for Patients with Tricuspid…
RT @NEJM: This week’s most cited articles: 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/ZWObb9Xl6T #ca…
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/V42XxYb4tZ
RT @ZHeart11768530: Don't miss !!!! This week’s most cited #cardiology articles @NEJM 1. Transcatheter Repair for Patients with Tricuspid…
RT @ZHeart11768530: Don't miss !!!! This week’s most cited #cardiology articles @NEJM 1. Transcatheter Repair for Patients with Tricuspid…
Don't miss !!!! This week’s most cited #cardiology articles @NEJM 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/XWmhJF0rDz 2. Intravascular Imaging–Guided or Angiography-Guided Complex PCI https://t.co/kgJGrZDlsi #CardioTwitter #cardioEd https://t.co/onwjcgmwxw
RT @NEJM: This week’s most cited articles: 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/ZWObb9Xl6T #ca…
RT @NEJM: This week’s most cited articles: 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/ZWObb9Xl6T #ca…
This week’s most cited articles: 1. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/ZWObb9Xl6T #cardiology https://t.co/JrGr819UMr
Reading through TRILUMINATE and getting to grips with pair win analysis/win ratios. I thought this helped. Let me know what you think... https://t.co/9zwuFZfLly https://t.co/Iun01Hubtj
If the right ventricle is the forgotten ventricle, then the tricuspid valve is the forgotten valve
Transcatheter Repair for Patients with #Tricuspid Regurgitation For More: https://t.co/w1wVNQt7MZ
RT @CardiacRehabNow: Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/xeHKydUcEE
RT @SwissHeartDoc: Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM #teer #cardiotwitter https://t.co/xnnTVEfpmq
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM #teer #cardiotwitter https://t.co/xnnTVEfpmq
RT @FH_Verbrugge: Proud of my student @GiulioMonde, joining us @HeartBrussels from beautiful
RT @FH_Verbrugge: Proud of my student @GiulioMonde, joining us @HeartBrussels from beautiful
Proud of my student @GiulioMonde, joining us @HeartBrussels from beautiful
@maor_elad @RayburnTom @PCRonline @FabienPraz @JGrapsa @hahn_rt https://t.co/ldMxLLnR78 Great case and result! However, Triluminate did not show any sign of benefit with regard to mortality or HF rehospitalization, only a modest improvement in QoL in a trial without sham control. So TEER is not necessarily the solution for the problem.
RT @EAPCIPresident: #EAPCI Members It's not too late
RT @EAPCIPresident: #EAPCI Members It's not too late
RT @EAPCIPresident: #EAPCI Members It's not too late
#EAPCI Members It's not too late
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
#EAPCI Members
RT @JMMComendador:
RT @JMMComendador:
RT @JMMComendador:
RT @EAPCIPresident:
RT @EAPCIPresident:
RT @CardioSM: 今回の目玉であろうTRですが、open labelでoutcomeがほぼKCCQに依存してるっていう点は、かなり慎重に解釈すべきですよね https://t.co/zHg4k3jZQD
RT @SamiAlnasserMD: https://t.co/V05l1d4aq1
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
RT @EAPCIPresident: #EAPCI Members
#EAPCI Members
三尖弁閉鎖不全症例に対する経カテーテル的修復術 P:症候性の三尖弁閉鎖不全症で薬物治療を1ヶ月以上受けている患者 I:TriClip+薬物治療 C:薬物治療のみ O:①1年間全死亡or三尖弁手術 ②心不全入院 ③1年後のQOL改善 (階層的複合エンドポイント) #JCメモ https://t.co/1iRN2Kv74s
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/m4ru1DwaFw
RT @ernestocardio: Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/ybNEicQhmE @mencardio @torresviera @E…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @DrWheatley: Transcatheter Repair for Patients with Tricuspid Regurgitation @NEJM https://t.co/FR6tzabero https://t.co/KwadfMqR8s
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
Transcatheter Repair for Patients with Tricuspid Regurgitation @NEJM https://t.co/FR6tzabero https://t.co/KwadfMqR8s
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @NEJM: For patients with severe tricuspid regurgitation, transcatheter edge-to-edge repair (TEER) has emerged as a safe and potentially…
RT @NEJM: For patients with severe tricuspid regurgitation, transcatheter edge-to-edge repair (TEER) has emerged as a safe and potentially…
RT @NEJM: For patients with severe tricuspid regurgitation, transcatheter edge-to-edge repair (TEER) has emerged as a safe and potentially…
RT @NEJM: For patients with severe tricuspid regurgitation, transcatheter edge-to-edge repair (TEER) has emerged as a safe and potentially…
RT @NEJM: For patients with severe tricuspid regurgitation, transcatheter edge-to-edge repair (TEER) has emerged as a safe and potentially…
RT @NEJM: For patients with severe tricuspid regurgitation, transcatheter edge-to-edge repair (TEER) has emerged as a safe and potentially…
For patients with severe tricuspid regurgitation, transcatheter edge-to-edge repair (TEER) has emerged as a safe and potentially effective treatment option. Read the full TRILUMINATE Pivotal trial Research Summary: https://t.co/ZWObb9WNhl
Un estudio positivo que luce negativo. Del desenlace primario combinado no impacta mortalidad ni hospitalización por falla; ni siquiera cirugía, solo calidad de vida por una escala. ¿Adecuado utilizar Win Ratio? ¿Más informativo? https://t.co/iUSwCCdKRJ
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
TEER for TR | @NEJM https://t.co/tlYzOU009H
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
RT @psorajja: #TRILUMINATE in press today! Great impactful results for untreated population. Moving forward for #TR! @NEJM @MHIF_Heart @All…
TR #ILUMINATE Trial Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/oANctWcYGC https://t.co/o0sEcjsYCs
RT @ernestocardio: Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/ybNEicQhmE @mencardio @torresviera @E…
RT @ernestocardio: Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/ybNEicQhmE @mencardio @torresviera @E…
NEJM 重症の三尖弁逆流症に対するカテーテル治療と内科加療の比較。 非盲検試験 結果 1年のフォローアップでは、カテーテルの方がQOLを向上させる #循環器 #麻酔 #論文 Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/MvHWXilmLX
RT @ernestocardio: Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/ybNEicQhmE @mencardio @torresviera @E…
RT @Susumu_Manabe: 重度の三尖弁閉鎖不全症に対するカテーテル治療 vs. 薬物治療の無作為化比較試験。残念ながら死亡や心不全入院では差がでず、生活の質はカテーテル治療で改善した。 Transcatheter Repair for Patients with T…
RT @ernestocardio: Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/ybNEicQhmE @mencardio @torresviera @E…
En pacientes con insuficiencia tricuspídea severa, la reparación percutánea mejoró su calidad de vida, pero no las hospitalizaciones por insuficiencia cardíaca o muerte. Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/E91KMdoupa
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/ybNEicQhmE @mencardio @torresviera @Ed_Alania @jpcostabel @drjarayg @jstragazue @igormorr @Lguevaramath @emartinezgmg @recetario1 @ramicule @CardiologiaSVC @secardiologia
RT @Susumu_Manabe: 重度の三尖弁閉鎖不全症に対するカテーテル治療 vs. 薬物治療の無作為化比較試験。残念ながら死亡や心不全入院では差がでず、生活の質はカテーテル治療で改善した。 Transcatheter Repair for Patients with T…
RT @Susumu_Manabe: 重度の三尖弁閉鎖不全症に対するカテーテル治療 vs. 薬物治療の無作為化比較試験。残念ながら死亡や心不全入院では差がでず、生活の質はカテーテル治療で改善した。 Transcatheter Repair for Patients with T…
RT @Susumu_Manabe: 重度の三尖弁閉鎖不全症に対するカテーテル治療 vs. 薬物治療の無作為化比較試験。残念ながら死亡や心不全入院では差がでず、生活の質はカテーテル治療で改善した。 Transcatheter Repair for Patients with T…
RT @Susumu_Manabe: 重度の三尖弁閉鎖不全症に対するカテーテル治療 vs. 薬物治療の無作為化比較試験。残念ながら死亡や心不全入院では差がでず、生活の質はカテーテル治療で改善した。 Transcatheter Repair for Patients with T…
重度の三尖弁閉鎖不全症に対するカテーテル治療 vs. 薬物治療の無作為化比較試験。残念ながら死亡や心不全入院では差がでず、生活の質はカテーテル治療で改善した。 Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/YLz7nwejZW https://t.co/ZMcLJi22Ce
RT @QxMD: Don't miss these discussions! #CardsJC Access the papers through Read beforehand: TRILUMINATE: https://t.co/ic9TbzyBxV CLEAR: ht…
Don't miss these discussions! #CardsJC Access the papers through Read beforehand: TRILUMINATE: https://t.co/ic9TbzyBxV CLEAR: https://t.co/GyOt7rRLUV RAPID-HF: https://t.co/xfPc5OKYLb https://t.co/oCTAKdH7Qx
Kudos to @whisenant_brian and colleagues on this publication last month in NEJM. Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/CRsTIP0m8O @SCWollerMD @Jess_Intermtn @ErinGoff18
Highlights from the #AmericanCollegeofCardiology on #transcatheterrepair for patients with #tricuspidregurgitation is today's #TripleI article theme, by Gabriel Kanhouche M.D. - https://t.co/31VnlZrEKz
Transcatheter Repair for Patients with Tricuspid Regurgitation https://t.co/oQH036nHgf
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @ValleAlfonso: #TRILUMINATE
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
RT @DrDamluji: Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Su…
Transcatheter Repair for Patients with Tricuspid Regurgitation: @NEJM #ACC23 #Trial Update1 TRILUMINATE Pivotal: 7 Point Summary
RT @medical_xpress: Reducing tricuspid #valve regurgitation with a minimally invasive clip improves quality of life, study finds @nejm http…
RT @medical_xpress: Reducing tricuspid #valve regurgitation with a minimally invasive clip improves quality of life, study finds @nejm http…
RT @medical_xpress: Reducing tricuspid #valve regurgitation with a minimally invasive clip improves quality of life, study finds @nejm http…
RT @medical_xpress: Reducing tricuspid #valve regurgitation with a minimally invasive clip improves quality of life, study finds @nejm http…
RT @medical_xpress: Reducing tricuspid #valve regurgitation with a minimally invasive clip improves quality of life, study finds @nejm http…
Reducing tricuspid #valve regurgitation with a minimally invasive clip improves quality of life, study finds @nejm https://t.co/0m0gVPjuyZ https://t.co/natrveAoYu
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM - https://t.co/nrcLN9xvy5 https://t.co/q98FL4Q8Mg≷=US&ceid=US:en
https://t.co/CnObqnm2SI≷=US&ceid=US:en Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM - https://t.co/gU1JOgVLS0
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM - https://t.co/KaT2vur7HZ https://t.co/QILBPfV9QH
RT @ValleAlfonso: #TRILUMINATE
RT @ValleAlfonso: #TRILUMINATE
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
RT @NEJM: Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#…
Original Article: Transcatheter Repair for Patients with Tricuspid Regurgitation (TRILUMINATE) https://t.co/ZWObb9Xl6T #ACC23/#WCCardio https://t.co/2SxtaCTQDm
RT @ValleAlfonso: #TRILUMINATE
RT @ValleAlfonso: #TRILUMINATE
RT @ValleAlfonso: #TRILUMINATE
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM - https://t.co/vIRovKNnXH https://t.co/4f2In7we9g #TrendingNow #HotTopics #Trending #News #NewsUpdate #Forumidex #MyForumLink
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/eMsIxKIojG
Transcatheter Repair for Patients with Tricuspid Regurgitation | NEJM https://t.co/9Pv1AYEffV
M
LA